Mark Michael Chung, MD
NPI 1740290378ActiveIndividual· Internal Medicine, Sleep Medicine· Cerritos, CA
Internal Medicine, Sleep Medicine (MD) in Cerritos, California, licensed in CA, with an NPI issued in August 2006. Their prescriptions cost Medicare Part D more than their services did: $136,953 for 992 claims, against $57,784 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 5 companies reporting payments in 2025, $1,158 in all, mostly food and beverage.
Overview
| NPI | 1740290378 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Aug 8, 2006 |
| Last updated in NPPES | Aug 27, 2026 |
| Certified by provider | Aug 27, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Sleep Medicine Primary | 207RS0012X | G52290 | CA |
| Internal Medicine, Pulmonary Disease | 207RP1001X | G52290 | CA |
| Internal Medicine | 207R00000X | G52290 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 160 |
|---|---|
| Services billed | 418 across 7 procedure codes |
| Paid by Medicare | $57,784 |
Part D prescriptions in 2024
| Prescriptions (claims) | 992 · 1,338 30-day fills |
|---|---|
| Patients | 308 |
| Total drug cost | $136,953 |
| Generic share | 76% of claims |
Education and affiliations
| Graduation year | 1982 |
|---|---|
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists), Internal Medicine |
Industry payments (Open Payments)
- 2025$1,158 · 55 payments from 5 companies
- 2024$747.27 · 32 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $805.67 | 39 |
| Glaxosmithkline, LLC. | $151.69 | 13 |
| Jazz Pharmaceuticals Inc. | $122.21 | 1 |
| Harmony Biosciences LLC | $54.99 | 1 |
| Ferring Pharmaceuticals Inc. | $23.00 | 1 |
What the 2025 payments were for
- Food and Beverage$1,103 · 54 payments
- Education$54.99 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records